Please login to the form below

Not currently logged in
Email:
Password:

Therachon poaches Shire’s Aled Williams

He becomes the biotech’s chief commercial officer and head of patient access

Aled WilliamsTherachon, a clinical-stage biotechnology company, has appointed Aled Williams to the position of chief commercial officer and head of patient access.

Williams has more than 25 years’ experience in healthcare and pharmaceuticals and most recently he served as vice president and global strategy head for rare gastrointestinal diseases at Shire.

There he was responsible for the commercialisation and development of Gattex/Revestive (teduglutide) for short bowel syndrome.

Williams said: “I am excited to be joining the talented leadership team at Therachon and I look forward to working with the Therachon team and the whole medical and patient community in developing TA-46, and advancing Therachon’s pipeline of drug candidates that aim to bring a transformational new therapy to those in the achondroplasia community.”

Prior to his time at Shire, Williams held leadership positions at Bristol-Myers Squibb, Novartis and Roche.

Commenting on the recent appointment, Luca Santarelli, chief executive officer of Therachon, said: “Aled has spent many years leading companies through the development of successful rare disease programmes, including the expansion of patient outreach and commercial capabilities.

“We believe his considerable leadership experience in rare diseases will contribute to Therachon’s continued growth as we move into the clinic, establish our network of key partners among clinicians and patient organisations.”

23rd March 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Women in science
The role of women in science and technology
Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
Maria Dahl
China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
China secures a place at the forefront of innovative medicine...
Virtual Research Grants Submission and Approval Program
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....

Infographics